𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer

✍ Scribed by Suzuki, R; Hasegawa, Y; Baba, K; Saka, H; Saito, H; Taniguchi, H; Yamamoto, M; Matsumoto, S; Kato, K; Oishi, T; Imaizumi, K; Shimokata, K


Book ID
127054259
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
92 KB
Volume
94
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES